Cargando…

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma

BACKGROUND: Hodgkin lymphoma (HL) survivors are at increased risk for developing valvular heart disease (VHD). We evaluated the determinants of the risk and the radiation dose-response. METHODS: A case-control study was nested in a cohort of 1852 five-year HL survivors diagnosed at ages 15 to 41 yea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cutter, David J., Schaapveld, Michael, Darby, Sarah C., Hauptmann, Michael, van Nimwegen, Frederika A., Krol, Augustinus D. G., Janus, Cecile P. M., van Leeuwen, Flora E., Aleman, Berthe M. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394894/ https://www.ncbi.nlm.nih.gov/pubmed/25713164 http://dx.doi.org/10.1093/jnci/djv008

Ejemplares similares

P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
por: Geurts, Yvonne M.G., et al.
Publicado: (2022)

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma
por: Geurts, Yvonne M., et al.
Publicado: (2023)

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors
por: de Vries, Simone, et al.
Publicado: (2018)

Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data
por: Juul, Sidsel Jacobsen, et al.
Publicado: (2022)

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics
por: de Vries, Simone, et al.
Publicado: (2018)

Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors
por: Roberti, Sander, et al.
Publicado: (2022)

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
por: van Eggermond, Anna M, et al.
Publicado: (2017)

Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
por: de Vries, Simone, et al.
Publicado: (2020)

P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
por: Lammers, Eline M.J., et al.
Publicado: (2022)

Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer
por: Rigter, Lisanne S., et al.
Publicado: (2022)

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors
por: Ykema, Berbel L. M., et al.
Publicado: (2021)

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy
por: Russell, Nicola S., et al.
Publicado: (2017)

Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA)
por: Krul, Inge M, et al.
Publicado: (2018)

Heart failure after treatment for breast cancer
por: Boekel, Naomi B., et al.
Publicado: (2019)

Surgical outcomes following breast reconstruction in patients with and without a history of chest radiotherapy for Hodgkin lymphoma: a multicentre, matched cohort study
por: Harmeling, J. Xavier, et al.
Publicado: (2023)

Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
por: Ykema, Berbel, et al.
Publicado: (2020)

T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
por: Neppelenbroek, Suzanne I.M., et al.
Publicado: (2022)

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009
por: Duane, Frances K., et al.
Publicado: (2022)

Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
por: Jacobse, Judy N., et al.
Publicado: (2019)

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
por: Ykema, Berbel L.M., et al.
Publicado: (2022)

P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
por: Nijdam, Annelies, et al.
Publicado: (2022)

Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies
por: Boot, Max V., et al.
Publicado: (2022)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
por: Rigter, Lisanne S., et al.
Publicado: (2017)

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
por: Boekel, Naomi B., et al.
Publicado: (2014)

Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases
por: Ykema, Berbel L. M., et al.
Publicado: (2020)

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
por: Boekel, Naomi B., et al.
Publicado: (2018)

Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
por: Wethal, T, et al.
Publicado: (2009)

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study
por: Busson, Raphaël, et al.
Publicado: (2019)

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
por: Ntentas, Georgios, et al.
Publicado: (2019)

Elevated resting heart rate is a marker of subclinical left ventricular dysfunction in hodgkin lymphoma survivors
por: Heemelaar, Julius C., et al.
Publicado: (2021)

P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment
por: Mieras, Adinda, et al.
Publicado: (2022)

PCR clonality detection in Hodgkin lymphoma
por: Hebeda, K. M., et al.
Publicado: (2009)

Cancer-related Fatigue in Relation to Chronotype and Sleep Quality in (Non-)Hodgkin Lymphoma Survivors
por: Starreveld, Daniëlle E. J., et al.
Publicado: (2021)

Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors
por: Polomski, Elissa A. S., et al.
Publicado: (2022)

Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years
por: Jacobse, Judy N., et al.
Publicado: (2019)

Long‐term hospitalisation rates among 5‐year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study
por: Rugbjerg, Kathrine, et al.
Publicado: (2017)

Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma
por: van Gils, Tom, et al.
Publicado: (2018)

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity
por: Daniëls, L A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b5l6bp2of277r51691o3iglg3e